Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/19/1996 | CA2288401A1 Icam-4 materials and methods |
12/19/1996 | CA2226463A1 Recombinational cloning using engineered recombination sites |
12/19/1996 | CA2224232A1 Methods, kits, and compositions for diagnosing papillomavirus infection |
12/19/1996 | CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses |
12/19/1996 | CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
12/19/1996 | CA2224174A1 Method for obtaining receptor agonist antibodies |
12/19/1996 | CA2224172A1 Use of gram-positive bacteria to express recombinant proteins |
12/19/1996 | CA2224144A1 Method of transferring at least two saccharide units with a polyglycosyltransferase |
12/19/1996 | CA2224114A1 Synthetic mammalian chromosome and methods for construction |
12/19/1996 | CA2224104A1 Recombinant production of novel polyketides |
12/19/1996 | CA2224099A1 Monocyte chemotactic protein-4 |
12/19/1996 | CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens |
12/19/1996 | CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family |
12/19/1996 | CA2224014A1 3' utr of the human prohibitin gene |
12/19/1996 | CA2224012A1 Developmentally-regulated endothelial cell locus-1 |
12/19/1996 | CA2224004A1 Transgenic plants co-expressing a functional human 2-5a system |
12/19/1996 | CA2223980A1 Chondroitinase production in recombinant proteus vulgaris strains |
12/19/1996 | CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
12/19/1996 | CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein |
12/19/1996 | CA2223934A1 Separation of active complexes |
12/19/1996 | CA2223928A1 Cationic lipid:dna complexes for gene targeting |
12/19/1996 | CA2223923A1 Cationic lipid:dna complexes for gene targeting |
12/19/1996 | CA2223891A1 Treatment of insulin resistance |
12/19/1996 | CA2223832A1 Method for the treatment of corticosteroid induced osteopenia |
12/19/1996 | CA2223775A1 Internal positive controls for nucleic acid amplification |
12/19/1996 | CA2223774A1 Detection of nucleic acids by formation of template-dependent product |
12/19/1996 | CA2223771A1 Catalytic dna |
12/19/1996 | CA2223717A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies |
12/19/1996 | CA2223637A1 A method of transfection of cells using liposomally encapsulated nucleic acids |
12/19/1996 | CA2223611A1 Appetite regulating compositions |
12/19/1996 | CA2223610A1 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | CA2223591A1 Recombinant fowlpox viruses and uses thereof |
12/19/1996 | CA2223584A1 Crosslinking oligonucleotides |
12/19/1996 | CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
12/19/1996 | CA2223549A1 Capped synthetic rna, analogs, and aptamers |
12/19/1996 | CA2223527A1 Linked linear amplification of nucleic acids |
12/19/1996 | CA2223519A1 Methods for evaluation of antimicrobial targets |
12/19/1996 | CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
12/19/1996 | CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
12/19/1996 | CA2223494A1 Chromosomal expression of heterologous genes in bacterial cells |
12/19/1996 | CA2223493A1 Recombinant viral nucleic acids |
12/19/1996 | CA2223459A1 Regulatory elements conferring tapetum specificity |
12/19/1996 | CA2223454A1 Molecular methods of hybrid seed production |
12/19/1996 | CA2223440A1 Fucosyltransferase genes and uses thereof |
12/19/1996 | CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
12/19/1996 | CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
12/19/1996 | CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons) |
12/19/1996 | CA2223277A1 Method for detection of antibody to hepatitis c virus second envelope glycoprotein |
12/19/1996 | CA2223275A1 High affinity nucleic acid ligands to lectins |
12/19/1996 | CA2223246A1 Cell line producing analgesic compounds for treating pain |
12/19/1996 | CA2223183A1 Anchor libraries and identification of peptide binding sequences |
12/19/1996 | CA2223181A1 Adenosine kinase polynucleotides |
12/19/1996 | CA2223179A1 Phosphonic acid-based cationic lipids |
12/19/1996 | CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation |
12/19/1996 | CA2223104A1 Pcr-based cdna subtractive cloning method |
12/19/1996 | CA2223086A1 Novel serpin derived from human hypothalamus |
12/19/1996 | CA2223077A1 Thrombin receptor homolog |
12/19/1996 | CA2223050A1 Probe masking method of reducing background in an amplification reaction |
12/19/1996 | CA2223041A1 Immunological combination compositions and methods |
12/19/1996 | CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein |
12/19/1996 | CA2223003A1 High-affinity nucleic acid ligands of cytokines |
12/19/1996 | CA2222999A1 Novel ctla4/cd28 ligands and uses therefor |
12/19/1996 | CA2222947A1 Inhibin compositions and methods of enhancing production performance |
12/19/1996 | CA2222941A1 A cytotoxicity-based genetic selection system (toxsel) |
12/19/1996 | CA2222793A1 Optimized minizymes and miniribozymes and uses thereof |
12/19/1996 | CA2222789A1 Bone stimulating factor |
12/19/1996 | CA2222761A1 Recombinant bacterial system with environmentally limited viability |
12/19/1996 | CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
12/19/1996 | CA2222574A1 Oral delivery of adeno-associated viral vectors |
12/19/1996 | CA2222562A1 Method for screening for receptor agonists and antagonists |
12/19/1996 | CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
12/19/1996 | CA2222534A1 In vitro packaging of adeno-associated virus dna |
12/19/1996 | CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna |
12/19/1996 | CA2222510A1 Template and primer based synthesis of enzymatically cleavable oligonucleotides |
12/19/1996 | CA2222305A1 Nucleic acid probes and amplification oligonucleotides for neisseria species |
12/19/1996 | CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells |
12/19/1996 | CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors |
12/19/1996 | CA2222174A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
12/19/1996 | CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer |
12/19/1996 | CA2222134A1 Monospecific antibodies against a subunit of fibrinogen |
12/19/1996 | CA2221986A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | CA2221747A1 Cotton fiber transcriptional factors |
12/19/1996 | CA2221726A1 Use of ovary-tissue transcriptional factors |
12/19/1996 | CA2221710A1 Gene therapy for myocardial ischemia |
12/19/1996 | CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | CA2221602A1 Essential oligonucleotides of vertebrate telomerase |
12/19/1996 | CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus |
12/19/1996 | CA2221521A1 Male infertility y-deletion detection with multiplex primer combinations |
12/19/1996 | CA2221480A1 Mutants of streptococcal toxin a and methods of use |
12/19/1996 | CA2221240A1 Controlling hemipteran insect pests with bacillus thuringiensis |
12/19/1996 | CA2221193A1 Chondroitinase i and chondroitinase ii producing mutants of p. vulgaris |
12/19/1996 | CA2220957A1 Glycine and phaseolus .alpha.-d-galactosidases |
12/19/1996 | CA2220952A1 Anti-allergy bispecific molecules |
12/19/1996 | CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | CA2220459A1 Expression of functional vertebrate phospholipases in yeast |
12/19/1996 | CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same |
12/19/1996 | CA2196972A1 Repellent compositions containing flavonoid aldehydes |